These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2956411)

  • 21. Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.
    Rowley M; Kulagowski JJ; Watt AP; Rathbone D; Stevenson GI; Carling RW; Baker R; Marshall GR; Kemp JA; Foster AC; Grimwood S; Hargreaves R; Hurley C; Saywell KL; Tricklebank MD; Leeson PD
    J Med Chem; 1997 Dec; 40(25):4053-68. PubMed ID: 9406596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding.
    Jones DR; Hall SD; Jackson EK; Branch RA; Wilkinson GR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):816-22. PubMed ID: 3385643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
    Wosilait WD; Ryan MP; Byington KH
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules.
    Shu HP; Bymun EN
    Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
    McDonnell PA; Caldwell GW; Masucci JA
    Electrophoresis; 1998 Mar; 19(3):448-54. PubMed ID: 9551800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
    Plum A; Müller LK; Jansen JA
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
    Oie S; Fiori F
    J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characterization of propofol binding to plasma proteins and possible interactions].
    Garrido MJ; Jiménez RM; Rodríguez-Sasiaín JM; Aguirre C; Aguilera L; Calvo R
    Rev Esp Anestesiol Reanim; 1994; 41(6):308-12. PubMed ID: 7838996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.
    Hamberger C; Barre J; Zini R; Taiclet A; Houin G; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(6):441-9. PubMed ID: 3468088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
    de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
    Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of site-specific binding to plasma albumin in drug availability to brain.
    Mandula H; Parepally JM; Feng R; Smith QR
    J Pharmacol Exp Ther; 2006 May; 317(2):667-75. PubMed ID: 16410405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood plasma proteins and drug transport across the hemato-encephalic barrier].
    Lutsevich AN; Bender KI; Kupchikov VV
    Farmakol Toksikol; 1991; 54(1):70-6. PubMed ID: 1860509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselective gallopamil protein binding.
    Gross AS; Eser C; Mikus G; Eichelbaum M
    Chirality; 1993; 5(6):414-8. PubMed ID: 8398599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of chlorpheniramine enantiomers to human plasma proteins.
    Hiep BT; Gimenez F; Khanh VU; Hung NK; Thuillier A; Farinotti R; Fernandez C
    Chirality; 1999; 11(5-6):501-4. PubMed ID: 10368923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.